Keyword :   immunotherapy

Pembrolizumab vs Placebo as Adjuvant Therapy for High-Risk Stage II Melanoma: Long-Term Follow-Up, Rechallenge, and Crossover in KEYNOTE-716
Т. 14, №4 (56)
Seven-year analysis of adjuvant pembrolizumab versus placebo in stage III melanoma in the EORTC1325 / KEYNOTE-054 trial
Т. 14, №4 (56)
KEYNOTE-006 study: results of 10-year follow-up of pembrolizumab versus ipilimumab in advanced melanoma
Т. 14, №4 (56)
From theory to practice. The art of lung cancer treatment
Т. 14, №3 (55)
Management of immunotherapy toxicity: European Society for Medical Oncology (ESMO) clinical guidelines for diagnosis, treatment and patient follow-up
Т. 14, №3 (55)
New therapeutic options in the treatment of patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Т. 14, №1 (53)
Immunological markers of dendritic cell vaccine response in glioblastoma patients
Authors: Skachkova O.V. Glavatskyi O.Ya. Zemskova O.V. Gorbach O.I.... Т. 14, №1 (53)
Expanding the role of immuno-oncology treatment in the management of patients with melanoma or triple-negative breast cancer
Т. 13, №4 (52)
Modern approaches to the diagnosis and treatment of lymphoproliferative diseases
Дата: 2023-12-06
Prospects for the use of pembrolizumab in the treatment of previously untreated patients with advanced malignant pleural mesothelioma
Author:Nemish I.L. Т. 13, № 3 (51)
The value of the immunotherapy of alfa/beta defensins in the development of epitheliitis in patients with oropharyngeal cancer
Authors: Hirna H.A. Kostyshyn I.D. Rozhko M.M. Lukach Ye.V.... Т. 11, № 3-4 (43-44)
World Conference on Lung Cancer 2020: new in the treatment of advanced/metastatic NSCLC
Т. 11, № 1-2 (41-42)
Five-year overall survival and progression-free survival of patients with advanced NSCLC receiving pembrolizumab
T. 10, № 3-4 (39-40)
The first experience of using dendritic cells immunotherapy in complex treatment of patients with glioblastoma in Ukraine
Authors: Khranovska N.M. Skachkova O.V. Gorbach O.I. Zhukova V.M.... Т. 9, № 2 (34) 2019
Immunotherapy in the treatment of melanoma patients: current state of the problem
Authors: Kukushkina M.M. Korovin S.I. Lytvynenko B.V. Т. 8, № 4 (32) 2018

1234